☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
P-II study
Innovent Reports the First Patient Dosing in P-II CIBI112A201 Trial of IBI112 for the Treatment of Plaque Psoriasis
September 24, 2021
Novartis Presents Results of Iptacopan in P-II Study for IgA Nephropathy at ERA-EDTA Congress
June 7, 2021
ViiV Healthcare Presents Results of GSK3640254 (GSK'254) in P-IIa study for the Treatment of HIV at CROI
March 10, 2021
Sanofi Entered into an Agreement with Merck to Conduct a P-II Study of THOR-707 in Sequenced Administration with MSD's KEYTRUDA (p...
October 30, 2020
Theravance Reports First Patient Dosing in a P-II Study of TD-0903 for Hospitalized Patients with Acute Lung Injury Associated wit...
June 25, 2020
Boehringer Ingelheim and Zealand Pharma to Initiate P-II Study of BI 456906 for Obesity and Diabetes
September 3, 2019
Load more...
Back to Home